HomeAbout us Management Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
Investors
Careers
News
Contact
|
 |
 |
 |
| Dr. Walter Fuhrer |
 |
| |
| Walter Fuhrer is an independent senior consultant in drug discovery with more than 25 years broad experience in conducting and managing medicinal chemistry and drug discovery. After completing a Ph.D. in organic chemistry at the Eidgenössische Technische Hochschule ETH in Zürich in 1973, he joined Ciba-Geigy AG (later Novartis) where he held different positions in medicinal chemistry and in research management both in Switzerland and in the United States. As Head of Cardiovascular Chemistry he was heavily involved in the discovery and development of Diovan®, a new blockbuster antihypertensive drug. After heading the Central Research Laboratories Basel of Ciba-Geigy AG for five years (until the merger with Sandoz) he then served as Head of Operations and Planning in Novartis' Oncology Research until 2001. He has served as reviewer on "The Journal of Medicinal Chemistry" and is presently a member of the editorial board of "Current Opinions in Drug Discovery and Development." |
[BACK] |

 |
© Copyright by Neurotune Switzerland |
|